The literature section indicates that ARID1A is observed in a variety of cancers including bladder cancer (Saito et al., 2018; Cao et al., 2020), ovarian cancer (Kim et al., 2016), liver cancer (Sun et al., 2017) and colon cancer (Mathur et al., 2017; Iftekhar et al., 2021). Here, ARID1A is linked to urinary bladder carcinoma.